Product Information
LAMIVUDINE 150 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.4887 per EA under NDC 00904658304. Its NADAC has been published 461 times since May 31, 2017.
FDA first approved this application on Dec 2, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904658304
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LAMIVUDINEApproval Type
Generic (ANDA)
FDA Application
ANDA091606FDA Approved
12/2/2011
TE Code
AB
On Market Since
12/2/2011
Pharmacological Classes
Price Statistics
The NADAC for LAMIVUDINE 150 MG TABLET has been published 461 times since May 31, 2017, and over the history we have for it it has declined 68.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4887 per EA |
|---|---|
| All-time high | $1.5942 (Jan 10, 2018) |
| All-time low | $0.4126 (Oct 22, 2025) |
| 52-week high | $0.4887 |
| 52-week low | $0.4126 |
| Median price | $0.8913 |
| Average price | $0.8871 |
| Largest weekly change | +54.1% (May 22, 2019) |
| Weeks tracked | 461 |
| Tracking since | May 31, 2017 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LAMIVUDINE 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LAMIVUDINE 150 MG TABLET, manufactured by Major Pharmaceuticals, is $0.4887 per EA (NDC 00904658304), effective Aug 19, 2026.
How has the price of LAMIVUDINE 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for LAMIVUDINE 150 MG TABLET has declined 68.1%. It has been tracked across 461 weekly CMS publications since May 31, 2017.
What are the highest and lowest recorded NADAC prices for LAMIVUDINE 150 MG TABLET?
Since May 31, 2017, the NADAC for LAMIVUDINE 150 MG TABLET has ranged from a low of $0.4126 (Oct 22, 2025) to a high of $1.5942 (Jan 10, 2018), with a median of $0.8913 per EA.
Are there cheaper alternatives to LAMIVUDINE 150 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LAMIVUDINE 150 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures LAMIVUDINE 150 MG TABLET?
LAMIVUDINE 150 MG TABLET (NDC 00904658304) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.